AWH

Aspira Women's Health Inc. | Cotação de Ações

Última atualização16/04/2025, 17:00:02

PreçoUS$ 0,08

Variação (dia)-- (0.00%)▼

Min. 52 SemanasUS$ 0,02

Máx. 52 SemanasUS$ 3,57

Capitalização de mercado--

Endereço: Building III, Austin, TX, 78738

Telefone: 512 519 0400

Funcionários: 66

Aspira Women's Health Inc.AWH

US$ 0,08

16/04/2025 17:00:02

1D 7D 1M 3M 1A Tudo

Visão geral da empresa

Preço atualUS$ 0,08

Valor de mercado--

AberturaUS$ 0,10

Preço máximoUS$ 0,08

Preço mínimoUS$ 0,08

VolumeUS$ 2,9 mi

Fechamento anteriorUS$ 0,08

Aspira Women's Health Inc., together with its subsidiaries, discovers, develops, and commercializes of noninvasive AI-powered diagnostic tests for gynecologic diseases in the United States. The company's products include Ova1Plus, a qualitative serum test to assess the likelihood of malignancy in women with an ovarian adnexal mass; Overa, a biomarker test intended to maintain Ova1's high sensitivity; and OvaWatch, a laboratory developed tests to assist in the initial clinical assessment of malignancy risk in all women thought to have an indeterminate or benign adnexal mass. It is also developing OvaMDx, a multi-marker test that combines serum proteins, clinical data, and miRNA for assessing the risk of ovarian cancer in women with an adnexal mass; EndoCheck, a protein biomarker designed to identify ovarian endometriomas; and EndoMDx for the identification of endometriosis. The company also operates Aspira Labs, a laboratory that specializes in applying biomarker-based technologies to address critical needs in the management of gynecologic cancers and disease. The company serves physicians, physician office laboratories, and national and regional laboratories. The company distributes its products through its national sales force, its platform Aspira Synergy, and a marketing and distribution agreement with BioReference Health, LLC. It has a research agreement with Harvard's Dana-Farber Cancer Institute, Brigham and Women's Hospital, and Medical University of Lodz for the generation of a multi-omic, non-invasive diagnostic aid to identify endometriosis based on circulating miRNAs and proteins; and a strategic alliance with Quest Diagnostics, Incorporated. The company was formerly known as Vermillion, Inc. and changed its name to Aspira Women's Health Inc. in June 2020. Aspira Women's Health Inc. was incorporated in 1993 and is based in Austin, Texas.

Ações relacionadas

AXIS Capital Holdings Limited

AXS ▼0.36% | US$ 90,45

Aspen Insurance Holdings Limited

AHL ▼0.00% | R$ 0,00

Prenetics Global Limited

PRE ▼0.18% | US$ 5,30

RenaissanceRe Holdings Ltd.

RNR ▼4.16% | US$ 259,06

Arch Capital Group Ltd.

ACGL ▼1.31% | US$ 95,21

Assine nossa newsletter para receber atualizações gratuitas por e-mail

Mantenha-se informado assinando nossa newsletter. Receba atualizações gratuitas por e-mail, incluindo rendimentos, novidades do mercado e insights valiosos. Estamos comprometidos em fornecer informações relevantes diretamente à sua caixa de entrada.

Fique por dentro das últimas notícias do mundo financeiro em nosso Blog

Mantenha-se atualizado com as últimas notícias financeiras em nosso Blog. Publicamos artigos informativos e análises de especialistas para fornecer insights valiosos sobre o cenário financeiro em constante evolução.

Acesse a Documentação para uma compreensão detalhada da nossa plataforma

Explore a Documentação para uma compreensão detalhada de como utilizar efetivamente nossa plataforma para análise de investimentos. Oferecemos recursos abrangentes para orientar investidores, desde iniciantes até experientes, na navegação por nossa plataforma.